Company Data
Regulus Therapeutics Inc.
Ticker
RGLS
Current Price
$7.93 -0.13%
Market Cap
$549.0M
Price Target
Refer to Report
Volume
1.0M
52wk Range
$0.8301 - $8.2
Overview
Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. MicroRNA is a noncoding ribonucleic acid that regulates most genes in the genome. The company partnered with Sanofi to create a compound targeting orphan diseases and with AstraZeneca to cure Type 2 Diabetes/prediabetes.